Tom Kean Jr.’s Depression Disclosure Challenges Mental Health Stigma

A sitting U.S. congressman has done something still rare in high-stakes politics: openly discuss his depression treatment. Rep. Tom Kean Jr. (R-NJ) disclosed that he is being treated for depression, challenging a culture that often equates mental health struggles with weakness. His admission, published in a candid personal statement, is a direct challenge to the stigma that keeps millions—especially those in demanding public roles—from seeking help.

Kean Jr., a moderate Republican from New Jersey, released the statement without a specific triggering event, noting instead that his decision was part of a broader commitment to transparency. 'For too long, mental health has been treated as a private failing rather than a medical condition,' he wrote. The disclosure is significant because it comes from a sitting member of Congress, a group known for projecting invulnerability. While several former lawmakers have spoken about mental health after leaving office, active politicians rarely share such details for fear of political repercussions or being seen as unfit for duty.

The context matters: America is in the midst of a mental health crisis. Rates of depression and anxiety have spiked, especially among younger adults, yet access to care remains uneven. Stigma—the fear of judgment or discrimination—remains a primary barrier to treatment. Kean Jr.'s disclosure lands at a moment when the public conversation around mental health has broadened, but institutional change has lagged. Politicians, in particular, operate in a hyper-competitive environment where any perceived weakness can be weaponized by opponents.

Kean Jr.'s decision to break the silence is notable for its timing and location. He is the son of former New Jersey governor Tom Kean Sr., a respected figure in state politics. The younger Kean has served in the House since 2023 and represents a competitive district. His willingness to acknowledge treatment suggests a calculation that authenticity may now outweigh the old risk of stigma. Several mental health advocacy groups, including the National Alliance on Mental Illness (NAMI), praised the move, calling it 'a powerful example for leaders everywhere.'

The implications extend beyond New Jersey. By going public, Kean Jr. joins a small but growing list of public figures—athletes, entertainers, and CEOs—who have normalized conversations about therapy and medication. But his role as an elected official adds a layer of political risk. Opponents could attempt to use the disclosure against him, though early reactions from both sides of the aisle have been largely supportive. Senior members of the House Republican Conference declined to comment, but several Democratic colleagues issued statements of solidarity.

Looking ahead, Kean Jr.'s disclosure could encourage more politicians and public employees to speak openly about their mental health without fear. It may also influence workplace policies on Capitol Hill, where staffers often operate under immense pressure with little support. Mental health experts say the most important outcome is that millions of Americans see a high-profile figure modeling the courage to seek help rather than suffer in silence. As one advocate noted, 'If a member of Congress can talk about depression, maybe the stigma really can shrink.'